COVID-19 infection in patients with systemic lupus erythematosus: Data from the Asia Pacific Lupus Collaboration

Int J Rheum Dis. 2020 Aug;23(9):1255-1257. doi: 10.1111/1756-185X.13937. Epub 2020 Aug 25.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Multicenter Study

MeSH terms

  • Adult
  • Asia / epidemiology
  • Australia / epidemiology
  • COVID-19 / epidemiology*
  • COVID-19 / immunology
  • COVID-19 / therapy
  • Female
  • Health Surveys
  • Humans
  • Immunocompromised Host
  • Immunosuppressive Agents / therapeutic use
  • Lupus Erythematosus, Systemic / drug therapy
  • Lupus Erythematosus, Systemic / epidemiology*
  • Lupus Erythematosus, Systemic / immunology
  • Middle Aged
  • New Zealand / epidemiology
  • Opportunistic Infections / epidemiology*
  • Opportunistic Infections / immunology
  • Opportunistic Infections / therapy
  • Treatment Outcome

Substances

  • Immunosuppressive Agents